• Nightingale Health converted 112,600 Series A shares into Series B shares, following shareholder requests.
• Post-conversion share count: 19,262,168 Series A; 40,647,779 Series B; 1,028,968 EMP; total unchanged at 60,938,915.
• Voting rights now total 233,269,459 votes.
• Conversions were registered on Sept. 28, 2026; converted shares start trading with existing shares on Sept. 29.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nightingale Health Oyj published the original content used to generate this news brief on September 28, 2026, and is solely responsible for the information contained therein.